Tirzepatide, the active ingredient in the diabetes drug Mounjaro, helped people lose more than 60 pounds (lb), or at least one-quarter of their body weight, when used along with intensive lifestyle ...

Researchers from Truveta, a health data analytics company, analyzed electronic health records for more than 18,000 adults, all of whom had overweight or obesity, who were using these medications in ...

Results from a recent study suggest that tirzepatide may be more effective in helping people who have obesity or overweight lose weight than semaglutide. People interested in using medications for ...

A winner has emerged in the ongoing battle of the bulge: Mounjaro. Overweight or obese adults are three times more likely to shed 15% of their body weight on Mounjaro than Ozempic, according to a ...

Eli Lilly’s weight loss injection tirzepatide — the ingredient inside its wildly popular drugs Mounjaro and Zepbound — could also help treat sleep apnea, according to research published Friday, a ...

Credit: Getty Images. The SURMOUNT-1 trial evaluated tirzepatide as an adjunct to a reduced-calorie diet and increased physical activity in adults without type 2 diabetes who have obesity or are ...

Overweight and obese patients taking weight loss and diabetes drug tirzepatide—the generic name for Mounjaro and Zepbound—saw significant reductions in their blood pressure, according to a new study ...